Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.

Volume: 6, Issue: 1, Pages: 4 - 4
Published: Feb 4, 2020
Abstract
Triple negative breast cancer (TNBC) comprises 15–20% of all invasive breast cancer and is associated with a poor prognosis. As therapy options are limited for this subtype, there is a significant need to identify new targeted approaches for TNBC patient management. The expression of the folate receptor alpha (FRα) is significantly increased in patients with TNBC and is therefore a potential biomarker and therapeutic target. We optimized and...
Paper Details
Title
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.
Published Date
Feb 4, 2020
Volume
6
Issue
1
Pages
4 - 4
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.